Target intelligence / Profile preview

Systemic fluid, electrolyte, and acid–base homeostasis

Molecular classification
Other
01

Overview

Systemic fluid, electrolyte, and acid–base homeostasis is the physiological process by which the body maintains the volume, composition, and pH of extracellular and intracellular fluids. This regulation is essential for cellular function, nerve conduction, and enzymatic activity, and is primarily managed by the kidneys, lungs, and endocrine system (StatPearls, 2023). The kidneys regulate the excretion of water and electrolytes like sodium and potassium, while the lungs control carbon dioxide levels to manage blood pH (NIH, 2022). Disruptions in these balances result in clinical conditions such as metabolic acidosis, hyponatremia, or hyperkalemia, which can lead to life-threatening complications like cardiac arrest or seizures. While this is a physiological state rather than a single molecular target, it is the functional objective of numerous therapeutic interventions. Pharmacological agents such as diuretics, ACE inhibitors, and mineralocorticoid receptor antagonists exert their effects by modulating specific molecular pathways within this broader homeostatic framework (PubMed, 2021). These drugs target specific transporters and receptors to restore equilibrium in patients with hypertension, heart failure, or renal disease.

Other names
Acid-base balanceFluid and electrolyte balanceInternal milieu regulationHomeostatic regulation of body fluids
02

Mechanism of action

Pharmacological agents modulate this physiological state by targeting specific molecular components such as ion transporters (e.g., NKCC2), enzymes (e.g., carbonic anhydrase), or receptors (e.g., V2 vasopressin receptor) to alter the excretion or retention of water and solutes (PubMed, 2021).

03

Biological functions

HomeostasisOsmoregulationAcid-base regulationRenal functionRespiratory gas exchange
04

Disease associations

Metabolic acidosisMetabolic alkalosisHyponatremiaHyperkalemiaChronic kidney diseaseHeart failureDiabetes insipidus
05

Safety considerations

Risk of acute kidney injuryCardiac arrhythmias due to electrolyte shiftsCerebral edema from rapid sodium correctionMetabolic derangements
06

Interacting drugs

Furosemide

5 more in the full profile.

07

Biomarkers

Serum sodiumSerum potassiumArterial blood gas (pH, pCO2, HCO3-)Serum creatinineUrine osmolarity

Beyond the preview

Go deeper on Systemic fluid, electrolyte, and acid–base homeostasis.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Systemic fluid, electrolyte, and acid–base homeostasis.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call